AI assistant
Sending…
SELLAS Life Sciences Group, Inc. — Director's Dealing 2015
Dec 30, 2015
33651_dirs_2015-12-29_f7140cb3-85fe-4b1e-9330-10e012ab71f4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Galena Biopharma, Inc. (GALE)
CIK: 0001390478
Period of Report: 2015-10-30
Reporting Person: Nejadnik Bijan (Executive VP and CMO)
More from SELLAS Life Sciences Group, Inc.
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 12
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 20
Major Shareholding Notification
2026
Jan 30
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9